An MHRA consultation is due to end on 31 August, with public comments on AQbD principles closing soon.
List view / Grid view
Regs & Legs
Filter the results
A complete response letter (CRL) has been sent to Dr Reddy’s for two generic products.
The DHSC has confirmed that several pharmaceutical industry bodies have agreed to NDAs regarding plans for a no-deal Brexit.
The CMA alleges that Aspen broke competition law, prompting the drug supplier to offer a payment and other compensations to the NHS.
Pretomanid in combination with bedaquiline and linezolid has been approved by the FDA for treatment-resistant tuberculosis of the lungs.
This series investigates the growing interest from the pharmaceutical industry in cannabinoids. In this first piece, we hear from industry experts about the current situation of the ingredient on the pharmaceutical market.
The European Commission has approved the drug for two indications: chronic lymphocytic leukaemia and Waldenström's macroglobulinemia.
In order keep up-to-date records and protect public health the FDA has announced it intends to deactivate out-of-date drug listings.
The MiniCapt Mobile Microbial Air Sampler allows the user to perform viable air sampling in cleanroom environments for classification and monitoring purposes.
Lidocaine topical cream and liquid gel products are being recalled as the lidocaine amount is higher than the label states.
The US District Court has decided in favour of Amgen’s Enbrel, ruling over Sandoz’s Erelzi in a patent conflict.
The US District Court has ruled in favour of Eli Lilly in the Alimta patent lawsuit against Dr. Reddy's Laboratories and Hospira, Inc.
The NICE and NHS have announced their draft recommendations for the prescribed use of cannabis-based treatments.
2019 has seen a marked increase of antibody biosimilar product approvals in the first half of the year, according to a report.